Observational analysis reveals outcomes of hormonal treatment in postmenopausal patients with endometrial cancer, suggesting a potential shift in treatment approaches.
The hormonal treatment with progestins, in low-grade G1 endometrioid endometrial cancers, has been approved as an alternative fertility-sparing treatment in young patients, under 40 years old, with fertility wishes and the possibility of close follow-up. However, it’s use in postmenopausal patients continues being debated. Objective: To analyze the short and medium-term results of conservative hormonal treatment applied to postmenopausal patients with low grade G1 endometroid endometrial cancer.
No takes yet. Share an insight, caveat, or question.
Soderini Alejandro (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: